Gentamicin and Neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Neoplasm malignant is reported as a side effect among people who take Gentamicin (gentamicin sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Neoplasm malignant when taking Gentamicin. It is created by eHealthMe based on reports of 21,523 people who have side effects when taking Gentamicin from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,541 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

21,523 people reported to have side effects when taking Gentamicin.
Among them, 26 people (0.12%) have Neoplasm malignant.

Could Gentamicin cause Neoplasm malignant?

Among these 26 people:

How long have people been on Gentamicin when they have Neoplasm malignant? *

What is the gender of people who have Neoplasm malignant when taking Gentamicin? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Neoplasm malignant when taking Gentamicin? *

What are other drugs people take besides Gentamicin? *

What are other side effects people have besides Neoplasm malignant? *

Stress And Anxiety: 16 people, 61.54%
Pain: 16 people, 61.54%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 53.85%
Abdominal Pain: 13 people, 50.00%
Constipation: 13 people, 50.00%
Exostosis (formation of new bone on the surface of a bone): 13 people, 50.00%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 50.00%
Pneumonia: 13 people, 50.00%
Metastases To Bone (cancer spreads to bone): 13 people, 50.00%
Hypokalemia (low potassium): 12 people, 46.15%

What are the existing conditions these people have? *

Diabetes: 9 people, 34.62%
Metastatic Neoplasm (spreadable cancer tumour): 9 people, 34.62%
Breast Cancer Metastatic: 9 people, 34.62%
Hypersensitivity: 9 people, 34.62%
Pain: 4 people, 15.38%
High Blood Pressure: 3 people, 11.54%
Hair Loss: 2 people, 7.69%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 7.69%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 7.69%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and have Neoplasm malignant?

- Check whether Neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gentamicin:

Gentamicin (21,654 reports)

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm malignant:

Neoplasm malignant (1,541 drugs)

Browse all the conditions that are associated with Neoplasm malignant:

Neoplasm malignant (1,261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate (the active ingredients of Gentamicin) and Gentamicin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.